Table 4 JIA-U Ocular Outcomes per affected eyes
From: Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy
JIA –U | Idiopathic Uveitis/Pars Plantis | |||||||
|---|---|---|---|---|---|---|---|---|
Current Study (n = 91) | Tugal-Tutkun [9] 1996 (n = 100) | Kadayifçilar [33] 2003 (n = 55) | Kump7 2005 (n = 165) | Current Study (n = 118) | Tugal-Tutkun9 1996 (n = 88) | Kadayifçilar [33] 2003 (n = 134) | Kump7 2005 (n = 202) | |
Cataract | 42 (26.3%) | 71 (71%) | 16 (32.7%) | 105 (64%) | 17 (14.4%) | 33 (37.5%) | 41 (30.6%) | 60 (29.6%) |
Glaucoma | 15 (9.4%) | 30 (30%) | 1 (2%) | 33 (20%) | 0 | 2 (2.3%) | 7 (5.2%) | 29 (14.4%) |
Band Keratopathy | 27 (16.9%) | 66 (66%) | 5 (10%) | 76 (46%) | 9 (7.6%) | 16 (18.2%) | 13 (9.7%) | 24 (11.9%) |
Post. Synechiae | 40 (25%) | – | – | 96 (58%) | 22 (18.6%) | – | – | 49 (24.3%) |
Optic Disc Swelling | 4 (2.5%) | 6 (6%) | 1 (2%) | 5 (3%) | 20 (16.9%) | 10 (11.4%) | 6 (4.5%) | 14 (6.9%) |
Hypotony | 5 (3.1%) | 19 (19%) | 3 (5.5%) | 17 (10%) | 1 (0.8%) | 2 (2.3%) | 1 (0.7%) | 1 (0.5%) |
Macular Oedema | 7 (4.4%) | – | – | – | 13 (11%) | – | – | – |
Vitreous Haemorrhage | 1 (0.6%) | 3 (3%) | 0 | 0 | 0 | 8 (5%) | 2 (1.5%) | 3 (1.5%) |
Epiretina Membranel | 0 | – | 1 (2%) | 17 (10%) | 1 (0.8%) | – | – | 20 (9.9%) |